We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRHC icon
3651
Freedom Holding
FRHC
$9.55B
$21K ﹤0.01%
+1,117
New +$18.6K
HACK icon
3652
Amplify Cybersecurity ETF
HACK
$3.01B
$21K ﹤0.01%
466
+362
+348% +$15K
LE icon
3653
Lands' End
LE
$402M
$21K ﹤0.01%
2,607
-469
-15% -$3.37K
OPBK icon
3654
OP Bancorp
OPBK
$233M
$21K ﹤0.01%
+2,989
New +$20.1K
PASG icon
3655
Passage Bio
PASG
$13.9M
$21K ﹤0.01%
39
+32
+457% +$14.4K
RES icon
3656
RPC Inc
RES
$1.36B
$21K ﹤0.01%
+6,804
New +$20.7K
SB icon
3657
Safe Bulkers
SB
$764M
$21K ﹤0.01%
+17,486
New +$19.2K
WATT icon
3658
Energous
WATT
$102M
$21K ﹤0.01%
12
VIRX
3659
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$21K ﹤0.01%
+2,248
New +$33.9K
SALM
3660
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$21K ﹤0.01%
+18,620
New +$17.7K
NETI
3661
DELISTED
Eneti Inc.
NETI
$21K ﹤0.01%
1,351
+1,043
+339% +$20.4K
HT
3662
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$21K ﹤0.01%
3,584
-2,344
-40% -$12.5K
ZYNE
3663
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$21K ﹤0.01%
+6,213
New +$29.4K
ELOX
3664
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$21K ﹤0.01%
174
+121
+228% +$13.7K
OXFD
3665
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$21K ﹤0.01%
1,610
-197
-11% -$2.37K
NTRP
3666
DELISTED
Neurotrope, Inc. Common
NTRP
$21K ﹤0.01%
+17,625
New +$22.1K
ARC
3667
DELISTED
ARC Document Solutions, Inc.
ARC
$21K ﹤0.01%
20,902
+20,026
+2,286% +$16.9K
ANIX icon
3668
Anixa Biosciences
ANIX
$111M
$20K ﹤0.01%
6,492
+1,330
+26% +$2.76K
APVO icon
3669
Aptevo Therapeutics
APVO
$5.01M
0
BBCP icon
3670
Concrete Pumping Holdings
BBCP
$473M
$20K ﹤0.01%
5,722
+1,462
+34% +$4.46K
BCE icon
3671
BCE
BCE
$21B
$20K ﹤0.01%
485
+405
+506% +$16.7K
CLRO icon
3672
ClearOne Inc
CLRO
$24M
$20K ﹤0.01%
652
+591
+969% +$16.5K
EIDO icon
3673
iShares MSCI Indonesia ETF
EIDO
$495M
$20K ﹤0.01%
1,149
+973
+553% +$16.3K
EWM icon
3674
iShares MSCI Malaysia ETF
EWM
$330M
$20K ﹤0.01%
793
+303
+62% +$7.4K
FARM
3675
DELISTED
Farmer Brothers
FARM
$20K ﹤0.01%
2,704
+309
+13% +$2.48K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.